Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cost of Revenue (2017 - 2020)

Historic Cost of Revenue for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Q4 2020 value amounting to $897000.0.

  • Ironwood Pharmaceuticals' Cost of Revenue fell 9185.51% to $897000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $3.1 million, marking a year-over-year decrease of 8686.49%. This contributed to the annual value of $3.1 million for FY2020, which is 8686.49% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Cost of Revenue stood at $897000.0 for Q4 2020, which was down 9185.51% from $2.2 million recorded in Q1 2020.
  • In the past 5 years, Ironwood Pharmaceuticals' Cost of Revenue ranged from a high of $21.5 million in Q4 2018 and a low of $506000.0 during Q3 2019
  • Moreover, its 4-year median value for Cost of Revenue was $3.8 million (2017), whereas its average is $5.6 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Cost of Revenue surged by 39096.05% in 2018 and then plummeted by 9185.51% in 2020.
  • Over the past 4 years, Ironwood Pharmaceuticals' Cost of Revenue (Quarter) stood at $9.0 million in 2017, then soared by 138.9% to $21.5 million in 2018, then tumbled by 48.69% to $11.0 million in 2019, then plummeted by 91.86% to $897000.0 in 2020.
  • Its Cost of Revenue stands at $897000.0 for Q4 2020, versus $2.2 million for Q1 2020 and $11.0 million for Q4 2019.